Everything by Chris.

Technology

Why This Analyst Sees 25% More Upside in Apple

Sep 8, 2020 Apps & Software

Sumo Logic Announces Potential Pricing of IPO

Sep 8, 2020 Health and Healthcare

Are More Positive Results on the Way for Kamada’s COVID-19 Pneumonia Treatment?

Sep 8, 2020 Health and Healthcare

Corbus Pharma Suffers Big Setback in Systemic Sclerosis Study

Sep 8, 2020 Technology

Does Broadcom Deserve More Credit For Q3?

Sep 3, 2020 Health and Healthcare

Safety Concern Offsets Chronic Kidney Disease Study Positive Results

Sep 3, 2020 Health and Healthcare

Auris Medical Makes Key Progress With Midstage Vertigo Trial

Sep 3, 2020 Retail

Are Investors Too Bearish on Conn’s Q2?

Sep 3, 2020 Technology

Is Cloudera Getting Enough Out of Its Q2 Results and Guidance?

Sep 3, 2020 Technology

CrowdStrike Gets An Earnings Shock in Q2

Sep 2, 2020 Companies and Brands

Why One Analyst Is Racing Ahead With a Street-High Target for Peloton

Sep 2, 2020 Casinos & Hotels

DraftKings Dunks on the Competition With Its Newest Teammate

Sep 2, 2020 Retail

Why Guess Is Another Retailer Bucking the COVID-19 Trend

Sep 2, 2020 Health and Healthcare

Why This Gilead Deal Is Huge For Jounce Therapeutics

Sep 1, 2020 Technology

Will Analysts Ever Catch Up to Zoom Video?

Sep 1, 2020 Retail

Will This Deal Keep J.Jill Alive?

Sep 1, 2020 Health and Healthcare

Plus Therapeutics Takes a Big Step in the Fight Against Brain Cancer

Sep 1, 2020 Investing

A Curious Second Vote of Confidence for Eastman Kodak

Sep 1, 2020 Technology

How Zoom Video’s Earnings Are Making the Case For The Best Coronavirus Stock

Aug 31, 2020 Health and Healthcare

Are Aimmune Shareholders Getting Enough in the Buyout?

Aug 31, 2020